Are there alternative avian influenza viruses for generation of stable attenuated avian-human influenza A reassortant viruses?
The present study evaluated gull influenza A viruses as donors of attenuating genes for the production of live, attenuated influenza A H1N1 and H3N2 avian-human (ah) reassortant viruses for use as vaccines to prevent disease due to influenza A viruses in humans. The previously evaluated duck influenza A viruses were abandoned as donors of attenuating avian influenza virus genes because clinical evaluation of H1N1 and H3N2 ah reassortant virus vaccines derived from duck viruses documented residual virulence of H1N1 reassortants for seronegative infants and young children. Gull influenza A viruses occupy an independent ecologic niche and are rarely isolated from species other than gulls. The possibility of using gull influenza A viruses as donors of internal gene segments in ah reassortant viruses was evaluated in the present study using three different gull viruses and three human influenza A viruses. Gull-human H3N2 reassortant influenza A viruses with the desired 6-2 genotype (six internal avian influenza virus genes and the two human influenza virus surface glycoprotein genes) were readily generated and were found to be attenuated for squirrel monkeys and chimpanzees. However, ah reassortant viruses with gull and human influenza A H1N1 genes were difficult to generate, and reassortants that had the desired genotype of six gull virus genes with human influenza A H1 and N1 genes were not isolated despite repeated attempts. The gull PB2, NP and NS genes were not present in any of the gull-human H1N1 reassortants generated. The under-representation of these three gene segments suggests that reassortants bearing one or more of these three gene segments might have reduced viability indicative of a functional incompatibility in their gene products. The difficulties encountered in the generation of a 6-2 gull-human H1N1 reassortant virus are sufficient to conclude that the gull influenza A viruses tested would not be useful as donors of sets of six internal genes to attenuate human influenza A viruses. This study also identifies influenza virus gene segments that appear to be incompatible for generation of reassortants. Elucidation of the molecular basis of this restriction may provide information on intergenic interactions involved in virion assembly or packaging.
Subbarao
K
K
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Webster
R G
RG
Kawaoka
Y
Y
Murphy
B R
BR
D000818:Animals; D002460:Cell Line; D002642:Chick Embryo; D002645:Chickens; D046508:Culture Techniques; D004285:Dogs; D005838:Genotype; D006801:Humans; D009980:Influenza A virus / Q000235:genetics*; D002679:Pan troglodytes; D016865:Reassortant Viruses / Q000235:genetics* / Q000302:isolation & purification / Q000502:physiology; D015203:Reproducibility of Results; D012453:Saimiri; D014613:Vaccines, Attenuated / Q000235:genetics / Q000302:isolation & purification; D014765:Viral Vaccines / Q000235:genetics / Q000302:isolation & purification; D014779:Virus Replication
D014613:Vaccines, Attenuated; D014765:Viral Vaccines